Molecular modeling approaches for the discovery of adenosine A2B receptor antagonists: current status and future perspectives

被引:16
|
作者
Deb, Pran Kishore [1 ]
Chandrasekaran, Balakumar [1 ]
Mailavaram, Raghuprasad [2 ]
Tekade, Rakesh Kumar [3 ]
Jaber, Abdul Muttaleb Yousef [1 ]
机构
[1] Philadelphia Univ, Philadelphia Univ Jordan, Fac Pharm, POB 1, Amman 19392, Jordan
[2] Sri Vishnu Coll Pharm, Pharmaceut Chem Div, Bhimavaram 534202, Andhra Pradesh, India
[3] NIPER, Opposite Air Force Stn Palaj, Gandhinagar 382355, Gujarat, India
关键词
PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; CRYSTAL-STRUCTURE; BINDING MODES; XANTHINE DERIVATIVES; DYNAMICS SIMULATIONS; MEDICINAL CHEMISTRY; AFFINITY; POTENT; QSAR;
D O I
10.1016/j.drudis.2019.05.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Adenosine receptors (ARs) are classified as A(1), A(2A),A(2B), and A(3) subtypes belonging to the superfamily of G-protein-coupled receptors (GPCRs). Several molecular modeling approaches have been developed for A(2B)AR and its antagonists, from the construction of a homology model, molecular docking, molecular dynamics (MD) simulations, and 3D quantitative structure-activity relationship (QSAR) modeling to pharmacophore modeling, each of which has different objectives and outcomes. In this review, we provide a systematic outline of advances in molecular modeling approaches towards A(2B)AR for deducing its structure and interactions with various types of antagonist. The information, methods and perspectives presented here provides impetus for medicinal chemists to discover potential ligands that can bind selectively with higher affinity to A(2B)AR.
引用
收藏
页码:1854 / 1864
页数:11
相关论文
共 50 条
  • [21] MOLECULAR MODELING OF ADENOSINE RECEPTOR ANTAGONISTS
    VANGALEN, PJM
    VANVLIJMEN, HWT
    IJZERMAN, AP
    SOUDIJN, W
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (06) : 339 - 339
  • [22] A structural study of new potent and selective antagonists to the A2B adenosine receptor
    Ferretti, V
    Pretto, L
    Tabrizi, MA
    Bertolasi, V
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS, 2005, 61 : 569 - 576
  • [23] In silico development of adenosine A2B receptor antagonists for sickle cell disease
    Rocha da Silva, Anna Carolina
    Carneiro Araujo, Janay Stefany
    da Rocha Pita, Samuel Silva
    Andrade Leite, Franco Henrique
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (20): : 9592 - 9601
  • [24] A patent review of adenosine A2B receptor antagonists (2016-present)
    Francucci, Beatrice
    Dal Ben, Diego
    Lambertucci, Catia
    Spinaci, Andrea
    Volpini, Rosaria
    Marucci, Gabriella
    Buccioni, Michela
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2022, 32 (06) : 689 - 712
  • [25] Improving Activity Prediction of Adenosine A2B Receptor Antagonists by Nonlinear Models
    Ghasemi, Fahimeh
    Mehri, Alireza
    Pena-Garcia, Jorge
    den-Haan, Helena
    Perez-Garrido, Alfonso
    Fassihi, Afshin
    Perez-Sanchez, Horacio
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING (IWBBIO 2015), PT II, 2015, 9044 : 635 - 644
  • [26] Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives
    Al-Attraqchi, Omar H. A.
    Attimarad, Mahesh
    Venugopala, Katharigatta N.
    Nair, Anroop
    Al-Attraqchi, Noor H. A.
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (25) : 2716 - 2740
  • [27] A2B Adenosine Receptor and Cancer
    Gao, Zhan-Guo
    Jacobson, Kenneth A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (20)
  • [28] Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes
    El Maatougui, Abdelaziz
    Azuaje, Jhonny
    Gonzalez-Gomez, Manuel
    Miguez, Gabriel
    Crespo, Abel
    Carbajales, Carlos
    Escalante, Luz
    Garcia-Mera, Xerardo
    Gutierrez-de-Teran, Hugo
    Sotelo, Eddy
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) : 1967 - 1983
  • [29] Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists
    Prieto-Diaz, Ruben
    Gonzalez-Gomez, Manuel
    Fojo-Carballo, Hugo
    Azuaje, Jhonny
    El Maatougui, Abdelaziz
    Majellaro, Maria
    Loza, Maria, I
    Brea, Jose
    Fernandez-Duenas, Victor
    Paleo, M. Rita
    Diaz-Holguin, Alejandro
    Garcia-Pinel, Beatriz
    Mallo-Abreu, Ana
    Estevez, Juan C.
    Andujar-Arias, Antonio
    Garcia-Mera, Xerardo
    Gomez-Tourino, Iria
    Ciruela, Francisco
    Salas, Cristian O.
    Gutierrez-de-Teran, Hugo
    Sotelo, Eddy
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (01) : 890 - 912
  • [30] Do adenosine receptor antagonists have an antidiabetic effect mediated by A2B receptors?
    Rüsing, D
    Müller, CE
    Verspohl, EJ
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R29 - R29